Showing results 1 to 1 of 1
Title | Author(s) | Issue Date | |
---|---|---|---|
Garadacimab for hereditary angioedema prophylaxis: long term efficacy and safety from the Phase 3 VANGUARD trial and first interim analysis of the open-label extension trial Proceeding/Conference:US HAEA National Summit (20/07/2023-23/07/2023, , , Florida) | 20-Jul-2023 |